Methergine oral and injection and Rituximab and hyaluronidase human, recombinant Subcutaneous

• Generic Name: methylergonovine
• Dosage Forms: tablet
• Other Brand Names: Methergine

Methergine is in a group of drugs called ergot alkaloids. It affects the smooth muscle of a woman's uterus, improving the muscle tone as well as the strength and timing of uterine contractions.

Methergine is used just after a baby is born, to help deliver the placenta (also called the "afterbirth"). It is also used to help control bleeding and to improve muscle tone in the uterus after childbirth.

Methergine may also be used for purposes not listed in this medication guide.

• Generic Name: hyaluronidase / rituximab
• Dosage Forms: n.a.
• Other Brand Names: Rituxan Hycela

Rituximab and hyaluronidase human, recombinant combination injection is used alone or together with other cancer medicines to treat follicular lymphoma and chronic lymphocytic leukemia (CLL). It is also used together with other medicines to treat diffuse large B-cell lymphoma (DLBCL) in people who have not received previous treatment.

Rituximab and hyaluronidase human, recombinant combination injection is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed by the body.

Rituximab and hyaluronidase human, recombinant is to be given only by or under the direct supervision of your doctor.